What is Omega Healthcare's earnings per share (EPS)?

Omega Healthcare (OHI) reported diluted earnings per share of $1.94 for fiscal year 2025. This represents a 25.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Omega Healthcare Financials

OHI

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Omega Healthcare (OHI) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 18 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Piotroski F-Score Neutral

6/9

Omega Healthcare passes 6 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

1.49x

For every $1 of reported earnings, Omega Healthcare generates $1.49 in operating cash flow ($878.6M OCF vs $590.2M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.2B

YoY+13.2%

5Y CAGR+5.9%

Omega Healthcare generated $1.2B in revenue in fiscal year 2025. This represents an increase of 13.2% from the prior year.

EBITDA

N/A

Net Income

$590.2M

YoY+45.2%

5Y CAGR+29.3%

10Y CAGR+9.7%

Omega Healthcare reported $590.2M in net income in fiscal year 2025. This represents an increase of 45.2% from the prior year.

EPS (Diluted)

$1.94

YoY+25.2%

5Y CAGR+22.6%

10Y CAGR+4.2%

Omega Healthcare earned $1.94 per diluted share (EPS) in fiscal year 2025. This represents an increase of 25.2% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$27.0M

YoY-94.8%

5Y CAGR-30.2%

10Y CAGR+17.4%

Omega Healthcare held $27.0M in cash against $4.3B in long-term debt as of fiscal year 2025.

Dividends Per Share

$2.68

YoY+0.0%

5Y CAGR+0.0%

10Y CAGR+2.1%

Omega Healthcare paid $2.68 per share in dividends in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Shares Outstanding

296M

YoY+4.9%

5Y CAGR+5.0%

10Y CAGR+4.7%

Omega Healthcare had 296M shares outstanding in fiscal year 2025. This represents an increase of 4.9% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

49.6%

YoY+10.9pp

5Y CAGR+31.3pp

Omega Healthcare's net profit margin was 49.6% in fiscal year 2025, showing the share of revenue converted to profit. This is up 10.9 percentage points from the prior year.

Return on Equity

11.4%

YoY+2.4pp

5Y CAGR+7.1pp

10Y CAGR+5.2pp

Omega Healthcare's ROE was 11.4% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 2.4 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

OHI Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$1.2B+13.2%	$1.1B+10.7%	$949.7M+8.1%	$878.2M-17.4%	$1.1B+19.1%	$892.4M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$104.1M+18.3%	$88.0M+8.0%	$81.5M+17.4%	$69.4M+7.4%	$64.6M+7.9%	$59.9M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$215.0M-3.0%	$221.7M-5.9%	$235.5M+1.0%	$233.2M-0.6%	$234.6M+5.0%	$223.4M
Income Tax	$14.7M+35.8%	$10.9M+73.6%	$6.3M+37.1%	$4.6M+18.8%	$3.8M-22.0%	$4.9M
Net Income	$590.2M+45.2%	$406.3M+67.8%	$242.2M-44.8%	$438.8M+2.5%	$428.3M+161.9%	$163.5M
EPS (Diluted)	$1.94+25.2%	$1.55+55.0%	$1.00-44.4%	$1.80+2.9%	$1.75+150.0%	$0.70

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$319.2M+2.4%	$311.6M+10.3%	$282.5M+2.1%	$276.8M-0.9%	$279.3M+1.2%	$276.0M+9.2%	$252.7M+3.9%	$243.3M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$24.5M+2.9%	$23.8M-0.3%	$23.8M-25.6%	$32.1M+42.1%	$22.6M+3.7%	$21.8M-1.8%	$22.1M+2.9%	$21.5M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$51.7M-11.0%	$58.1M+9.9%	$52.9M+1.2%	$52.3M-5.4%	$55.2M+1.0%	$54.7M+1.3%	$54.0M-6.7%	$57.8M
Income Tax	$2.1M-52.6%	$4.5M-1.0%	$4.5M+25.4%	$3.6M+21.1%	$3.0M-10.1%	$3.3M+67.5%	$2.0M-23.3%	$2.6M
Net Income	$164.8M-8.3%	$179.7M+31.6%	$136.6M+25.3%	$109.0M-3.8%	$113.3M+1.4%	$111.8M-1.8%	$113.9M+69.0%	$67.4M
EPS (Diluted)	N/A	$0.59+28.3%	$0.46+39.4%	$0.33	N/A	$0.42-6.7%	$0.45+66.7%	$0.27

OHI Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$10.0B+1.5%	$9.9B+8.6%	$9.1B-3.1%	$9.4B-2.4%	$9.6B+1.5%	$9.5B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$27.0M-94.8%	$518.3M+17.1%	$442.8M+49.0%	$297.1M+1346.9%	$20.5M-87.4%	$163.5M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$644.6M+0.1%	$643.7M0.0%	$643.9M+0.1%	$643.2M-1.3%	$651.4M0.0%	$651.7M
Total Liabilities	$4.6B-10.8%	$5.2B-3.5%	$5.4B-4.4%	$5.6B+1.3%	$5.5B+1.3%	$5.5B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$4.3B-12.0%	$4.8B-4.5%	$5.1B-4.2%	$5.3B+0.6%	$5.3B+1.6%	$5.2B
Total Equity	$5.2B+14.2%	$4.5B+26.9%	$3.6B-1.0%	$3.6B-7.6%	$3.9B+1.7%	$3.8B
Retained Earnings	$4.7B+14.4%	$4.1B+11.0%	$3.7B+7.0%	$3.4B+14.2%	$3.0B+16.1%	$2.6B

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$10.0B-5.2%	$10.6B+0.5%	$10.5B+8.7%	$9.7B-1.9%	$9.9B+3.4%	$9.6B+8.2%	$8.8B-1.8%	$9.0B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$27.0M-96.3%	$737.2M+0.4%	$734.2M+99.5%	$368.0M-29.0%	$518.3M+51.4%	$342.4M+873.0%	$35.2M-90.3%	$361.8M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$644.6M0.0%	$644.6M0.0%	$644.9M+0.1%	$644.1M+0.1%	$643.7M-0.1%	$644.6M+0.1%	$643.8M0.0%	$643.8M
Total Liabilities	$4.6B-13.9%	$5.4B-0.1%	$5.4B+12.2%	$4.8B-7.6%	$5.2B-0.1%	$5.2B+4.5%	$4.9B-6.8%	$5.3B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$4.3B-14.8%	$5.0B-0.1%	$5.0B+12.5%	$4.4B-8.1%	$4.8B-0.4%	$4.9B+4.2%	$4.7B-7.3%	$5.0B
Total Equity	$5.2B+2.9%	$5.0B+1.0%	$5.0B+5.2%	$4.7B+4.5%	$4.5B+7.8%	$4.2B+13.4%	$3.7B+5.6%	$3.5B
Retained Earnings	$4.7B+3.7%	$4.5B+4.1%	$4.3B+3.3%	$4.2B+2.7%	$4.1B+2.9%	$4.0B+2.9%	$3.9B+3.0%	$3.7B

OHI Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$878.6M+17.2%	$749.4M+21.3%	$617.7M-1.3%	$625.7M-13.4%	$722.1M+2.0%	$708.3M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$539.8M+19.6%	-$671.2M-87064.2%	-$770K-100.2%	$442.9M+184.5%	-$524.2M-488.6%	-$89.1M
Financing Cash Flow	-$838.3M-3285.0%	$26.3M+105.6%	-$473.3M+40.0%	-$789.4M-131.4%	-$341.1M+29.7%	-$485.5M
Dividends Paid	$780.4M+13.9%	$685.4M+6.5%	$643.9M+1.7%	$632.9M-0.7%	$637.6M+4.1%	$612.3M
Share Buybacks	N/A	N/A	N/A	$142.3M	N/A	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	$230.6M+1.7%	$226.7M-5.2%	$239.3M+31.5%	$182.0M-20.5%	$229.0M+23.8%	$184.9M+0.4%	$184.1M+21.5%	$151.5M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$11.7M+86.0%	-$83.8M+81.9%	-$463.5M-2506.7%	$19.3M+106.8%	-$281.7M-111.1%	-$133.5M+36.0%	-$208.5M-339.4%	-$47.5M
Financing Cash Flow	-$940.5M-576.3%	-$139.1M-123.6%	$589.0M+269.4%	-$347.7M-242.8%	$243.4M-9.2%	$268.1M+189.6%	-$299.2M-60.8%	-$186.0M
Dividends Paid	$198.4M+0.1%	$198.2M+1.9%	$194.6M+2.8%	$189.2M+4.3%	$181.4M+4.7%	$173.3M+4.4%	$166.0M+0.7%	$164.8M
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

OHI Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	49.6%+10.9pp	38.6%+13.2pp	25.5%-24.5pp	50.0%+9.7pp	40.3%+22.0pp	18.3%
Return on Equity	11.4%+2.4pp	9.0%+2.2pp	6.8%-5.4pp	12.2%+1.2pp	11.0%+6.7pp	4.3%
Return on Assets	5.9%+1.8pp	4.1%+1.4pp	2.7%-2.0pp	4.7%+0.2pp	4.4%+2.7pp	1.7%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	0.82-0.2	1.07-0.4	1.42-0.0	1.46+0.1	1.340.0	1.35
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	51.6%-6.0pp	57.7%+9.3pp	48.4%+9.0pp	39.4%-1.2pp	40.6%+0.1pp	40.5%-4.6pp	45.1%+17.4pp	27.7%
Return on Equity	3.2%-0.4pp	3.6%+0.8pp	2.7%+0.4pp	2.3%-0.2pp	2.5%-0.2pp	2.7%-0.4pp	3.1%+1.2pp	1.9%
Return on Assets	1.6%-0.1pp	1.7%+0.4pp	1.3%+0.2pp	1.1%-0.0pp	1.1%-0.0pp	1.2%-0.1pp	1.3%+0.5pp	0.8%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	0.82-0.2	0.99-0.0	1.00+0.1	0.94-0.1	1.07-0.1	1.15-0.1	1.26-0.2	1.43
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

Healthpeak Properties Inc DOC

$11.5B

Ventas VTR

$39.6B

Caretrust CTRE

$8.6B

AMERICAN HEALTHCARE REIT INC AHR

$9.0B

Welltower Inc WELL

$141.2B

Frequently Asked Questions

What is Omega Healthcare's annual revenue?

Omega Healthcare (OHI) reported $1.2B in total revenue for fiscal year 2025. This represents a 13.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Omega Healthcare's revenue growing?

Omega Healthcare (OHI) revenue grew by 13.2% year-over-year, from $1.1B to $1.2B in fiscal year 2025.

Is Omega Healthcare profitable?

Yes, Omega Healthcare (OHI) reported a net income of $590.2M in fiscal year 2025, with a net profit margin of 49.6%.

How much debt does Omega Healthcare have?

As of fiscal year 2025, Omega Healthcare (OHI) had $27.0M in cash and equivalents against $4.3B in long-term debt.

What is Omega Healthcare's net profit margin?

Omega Healthcare (OHI) had a net profit margin of 49.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Omega Healthcare pay dividends?

Yes, Omega Healthcare (OHI) paid $2.68 per share in dividends during fiscal year 2025.

What is Omega Healthcare's return on equity (ROE)?

Omega Healthcare (OHI) has a return on equity of 11.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Omega Healthcare's operating cash flow?

Omega Healthcare (OHI) generated $878.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Omega Healthcare's total assets?

Omega Healthcare (OHI) had $10.0B in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does Omega Healthcare have outstanding?

Omega Healthcare (OHI) had 296M shares outstanding as of fiscal year 2025.

What is Omega Healthcare's debt-to-equity ratio?

Omega Healthcare (OHI) had a debt-to-equity ratio of 0.82 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Omega Healthcare's return on assets (ROA)?

Omega Healthcare (OHI) had a return on assets of 5.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Omega Healthcare's Piotroski F-Score?

Omega Healthcare (OHI) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Omega Healthcare's earnings high quality?

Omega Healthcare (OHI) has an earnings quality ratio of 1.49x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.